These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3047706)

  • 1. The peripheral sympathetic nervous system. Its role in normal and pathologic anxiety.
    Hoehn-Saric R; McLeod DR
    Psychiatr Clin North Am; 1988 Jun; 11(2):375-86. PubMed ID: 3047706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
    Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
    Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic arousal moderates self-reported physiological arousal symptoms at baseline and physiological flexibility in response to a stressor in generalized anxiety disorder.
    Fisher AJ; Granger DA; Newman MG
    Biol Psychol; 2010 Mar; 83(3):191-200. PubMed ID: 20036309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential diagnosis of anxiety. Psychiatric and medical disorders.
    Cameron OG
    Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the sympathetic nervous system in anxiety: Is it possible to relieve anxiety with endoscopic sympathetic block?
    Pohjavaara P; Telaranta T; Väisänen E
    Nord J Psychiatry; 2003; 57(1):55-60. PubMed ID: 12745792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies.
    Kalk NJ; Nutt DJ; Lingford-Hughes AR
    J Psychopharmacol; 2011 Jan; 25(1):3-16. PubMed ID: 20530586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes.
    Chaudieu I; Beluche I; Norton J; Boulenger JP; Ritchie K; Ancelin ML
    J Affect Disord; 2008 Mar; 106(3):307-13. PubMed ID: 17727959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventromedial prefrontal lesions result in paradoxical cardiovascular activation with emotional stimuli.
    Hilz MJ; Devinsky O; Szczepanska H; Borod JC; Marthol H; Tutaj M
    Brain; 2006 Dec; 129(Pt 12):3343-55. PubMed ID: 17082198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine receptor systems and anxiety disorders.
    Heninger GR; Charney DS
    Psychiatr Clin North Am; 1988 Jun; 11(2):309-26. PubMed ID: 2843838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic characteristics of generalized anxiety disorder and worry.
    Thayer JF; Friedman BH; Borkovec TD
    Biol Psychiatry; 1996 Feb; 39(4):255-66. PubMed ID: 8645772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone on normals and chronically anxious patients.
    Hoehn-Saric R; Masek BJ
    Biol Psychiatry; 1981 Nov; 16(11):1041-50. PubMed ID: 7349618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study.
    Bruder GE; Fong R; Tenke CE; Leite P; Towey JP; Stewart JE; McGrath PJ; Quitkin FM
    Biol Psychiatry; 1997 May; 41(9):939-48. PubMed ID: 9110099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disturbance in anxiety disorders.
    Papadimitriou GN; Linkowski P
    Int Rev Psychiatry; 2005 Aug; 17(4):229-36. PubMed ID: 16194794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability in coronary artery disease patients with and without panic disorder.
    Lavoie KL; Fleet RP; Laurin C; Arsenault A; Miller SB; Bacon SL
    Psychiatry Res; 2004 Oct; 128(3):289-99. PubMed ID: 15541787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity.
    Meerlo P; Sgoifo A; Suchecki D
    Sleep Med Rev; 2008 Jun; 12(3):197-210. PubMed ID: 18222099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.